in other cell types, including macrophages, dendritic cells, endothelial cells and vascular smooth muscle cells 6 . The past 25 years have seen an expansion of research into podosomes and invadopodia, including the discover y of proteins associated with these structures, of stimuli required for their formation and of their in vivo relevance (TABLE 1; TIMELINE) . However, the control of their formation, and their function in vivo, remains enigmatic.
Given that the terms podosome and invadopodiu m were first used to describe the same structures in the same cells -the ventral protrusions of v-src-transformed fibroblasts -it is hardly surprising that confusion surrounds the nomenclature. Typically, structures of this type are referred to as podosomes when they are found in normal cells and as invadopodia when they are found in cancer cells. But, what term should we use to describe the structures in SRC-transformed cells, in which the structures were originally described? Some researchers have used podosomes and invadopodia interchangeably in this case, no doubt adding to the confusion. However, these cells are truly cancer cells, faithfully mimicking all the tumorigenic properties of the fibrosarcomas that are caused by RSV in its native host. Therefore, going forward, we advise using the term invadopodia to describe SRC-transformed fibroblasts but recommend using both search terms, and noting the cell type under study, when evaluating the older literature. A final comment
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on nomenclature: most recently, a catch-all term -the invadosome -has been introduced to describe all adhesive structures that are involved in ECM degradation and invasion. This term can be convenient when no distinction is being made between podosomes and invadopodia. However, it would seem premature to replace the original terms until, and unless, it becomes clear that podosomes and invadopodia are identical. In this Review, we use the 'normal cells have podosomes' and 'cancer cells have invadopodia' rule.
Our focus in this Review is on recent progress in understanding how podosome and invadopodium formation and function are regulated, and how these structures affect development and disease. We discuss individual podosome and invadopodium components in this context.
Characteristics of podosomes and invadopodia
Both podosomes and invadopodia are characteristically composed of an actin-rich core that is surrounded by adhesion and scaffolding proteins 7 . A chorus of actin nucleators, polymerization activators, actin-binding and actin-crosslinking proteins, kinases, small GTPases and scaffold proteins regulate the actin machinery within these dynamic structures 6 , with the half-life of actin turnover ranging from minutes to a few hours. Key players include the adaptor proteins Tyr kinase sub strate with four SH3 domains (TKS4) and Tyr kinase substrate with five SH3 domains (TKS5), the actin regulators cortactin and neural WiskottAldrich syndrome protein (N-WASP), the Tyr kinase SRC, and the transmembrane membrane type 1 matrix metalloprotease (MT1MMP; also known as MMP14). Some of these proteins are shown in FIG. 1, but readers are referred to other recent reviews for comprehensiv e descriptions of all the molecular components of podosomes and invadopodia 6, [8] [9] [10] .
Are podosomes and invadopodia in fact distinct structures? Here, opinion differs. Some take the view that they vary in both structure and function. Others consider the fact that there is no precedent for cancer cells 'inventing' new mechanisms (rather than co-opting and dysregulating normal cellular processes) to argue that they are, in essence, identical structures. Nevertheless, although podosomes and invadopodia are similar in overall architecture and function, morphological and molecular distinctions have been noted (TABLE 1) . For example, previous studies have suggested that invadopodia protrude further into the ECM than the minimal protrusions of podosomes and that invadopodia are stable for hours compared with the rapid turnover of podosomes; these observations may account for the higher degradative ability of cancer cells 11 . More recently, total internal reflection fluorescence (TIRF) microscopy studies suggested that invadopodia are part of a superstructure that is composed of a core with filamentlike invadopodia emanating from it and is found in areas of membrane ruffling 12 . By contrast, podosomes neither exhibit intense membrane ruffling nor form filamentlike processes 12 . However, it has recently been shown that under appropriate culture conditions, dendritic cells can form long podosomes that protrude into the ECM and degrade it 13 . It remains to be determined how many of the perceived differences will be explained by the culture conditions or the cell type being examined.
It is also important to distinguish podosomes and invado podia from other cellular protrusions, such as filopodia and lamellipodia, and from other adhesive structures, such as focal adhesions. Each has distinct morpho logical characteristics (TABLE 1) and forms in a distinct spatial location in cells growing in two dimensions (2D). However, these structures share several common proteins, particularly those that orchestrate actin polymerization 6, 14 . Therefore, it is necessary to consider protein and lipid composition, morphology and localization to Timeline | Highlights from 25 years of podosome and invadopodium research   1985  1988  1989  1990  1994  1997  1999  2000  2005  2006  2008  2009  2010 Podosomes are found in the osteoclasts that are adhering to bone laminae 5 .
Actin-and phosphotyrosine-rich ventral protrusions are recognized as cell attachment points to the ECM, and are given the name of podosomes 2 .
The discovery that SRC localizes to the sites of cell contact with the extracellular matrix (ECM), and that ECM degradation occurs at these sites 3 .
SRC-enriched sites of degradation are shown to be identical to the actin-rich protrusions known as podosomes.
The new name of invadopodia is coined 4 .
The first description of invadopodium-dependent proteolytic activity in human cancer cells 143 .
The first identification of a podosome-associated disease, Wiskott-Aldrich syndrome 50 .
The adaptor protein Tyr kinase substrate with five SH3 domains (TKS5) is shown to promote invadopodium formation and to be required for the invasive behaviour of human cancer cells 32 .
The demonstration that ECM rigidity promotes invadopodium activity 41 .
The detailed visualization of invadopodium elongation as cells traverse the basement membrane 42 .
The first description of podosome structure and invasion in three dimensions, demonstrating that podosomes invade the ECM using a mechanism that is similar to the one used by invadopodia 13 .
Bone resorption by osteoclasts is shown to require the podosome belt. This is the first physiological process that is shown to require podosomes 142 .
The discovery that membrane type 1 matrix metalloprotease (MT1MMP) is located in podosomes and invadopodia and is required for cancer cell invasion 144, 145 .
The demonstration that microtubules are required for podosome formation 98 .
( [2006] [2007] [2008] In vivo studies show that invadopodiumassociate d proteins are required for both tumour growth and metastasis 52, 54 .
Reactive oxygen species are found to be necessary for podosome and invadopodium formation 29 .
(2009-2010) The first demonstration that vascular pathophysiology involves podosome formation 20, 21 and that podosomes exist in vivo 20 .
distinguish between them (TABLE 1) . In particular, the colocalization of ventral actin puncta with focal degradation of the ECM is a valuable means to distinguish podosomes and invadopodia from other membrane structures (FIG. 2) .
Function of podosomes and invadopodia
It is thought that podosomes or invadopodia allow a cell to coordinate ECM degradation with cell motility, in order to facilitate cell migration through tissue microenvironments. Cell migration is required during embryonic development and, in adults, in response to injury and infection. Abnormal cell migration can underlie developmental, vascular and immune diseases, as well as tumour metastasis. In keeping with this, podosomes are found in cell types that are involved in tissue remodelling and immune surveillance, and the presence of invadopodia correlates with the ability of cancer cells to invade and metastasize. The maturation process for podosomes and invadopodia involves the recruitment and activation of multi ple pericellular proteases that facilitate ECM degradatio n 15, 16 and perhaps also ECM-independent events such as cytokine release (TABLE 1) . There are three main classes of protease that are present in podosomes and invadopodia: zinc-regulated metalloproteases (matrix metalloprotease 2 (MMP2), MMP9, MT1MMP and the ADAM (a disintegrin and metalloprotease) family of sheddases); the cathepsin Cys proteases; and the Ser proteases (seprase and urokinase plasminogen activator surface receptor (UPAR)) 9, 17 . It is generally accepted that the invadopodia that are formed in human cancer cells and SRC-transformed cells degrade the ECM. However, there is some debate about the role of podosomes in ECM degradation. Earlier studies observed only shallow ECM degradation in podosome-containing cells 17 , and degradative ability was once thought to distinguish invadopodia from podosomes 18 . However, more recent studies in vascular smooth muscl e cells, dendritic cells and endothelial cells have shown the degradation of ECM by podosomes 13, [19] [20] [21] [22] . From these and other studies, it seems that ECM degradation by podosomes is likely to be dependent on cell type and ECM substrate. Perhaps podosomes also have a degradation-independent role in cell migration.
How might podosomes and invadopodia control cell motility? Planar cell migration is facilitated by the coordination of focal adhesion assembly, maturation and turnover with the protrusion of the leading edge at lamellipodia 23 . Collective cell migration requires the MT1MMP-mediated degradation of collagen to generate the ECM tracks through which these groups of cells move 24 . In addition, mechanical forces are recognized to have important roles, both in the formation of focal adhesions and in the growth of adhesion-anchored stress fibres. 
Microtubule dependence
They induce lamellipodium extension 132 Regulates filopodium density in lamellipodium-rich areas 135 Inhibition of microtubules leads to increased focal adhesions 139 Required for elongation and/or formation 13, 98 Required for elongation but not formation 42 
Pericellular proteolysis

Minimal
133
No Minimal Yes, through MT1MMP and UPAR 13, 141 Yes, through MMP2, MMP9, MT1MMP, seprase, UPAR, ADAM12, ADAM15 and ADAM19 
Duration of structure
Podosome belt
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Recently, podosomes and invadopodia were also shown to act as mechanosensors and to exert traction on the underlying matrix, in a process requiring MT1MMP 25, 26 . More insight is likely to be obtained by investigating the dynamics of the actin comet-based structures of invadopodia, which consist of a stationary head that is localized to degradative patches and a tail that is motile 27 . Interestingly, these structures dis appear during cell migration. A detailed understanding of the mechanism by which podosomes and invadopodia facilitate cell migration is not yet available and is not discussed here.
Visualizing podosomes and invadopodia
We have introduced the concept that podosomes and invadopodia can be distinguished from other protrusive and adhesive structures by a careful analysis of their morphology and protein and lipid composition. Below, we review their morphological characteristics.
Podosomes and invadopodia in 2D. Both podosomes and invadopodia are usually visualized by staining them with phalloidin (which binds to filamentous actin (F-actin), an obligate component of these structures) and also with antibodies against other associated proteins such as the actin nucleator complex ARP2/3 or cortactin, which promotes the polymerization and rearrangement of the actin cytoskeleton. Because these proteins also colocalize with F-actin in other cellular structures, it is important to determine that the staining is on the ventral surface of the cell, using either confocal or TIRF microscopy. As an alternative, the presence of both F-actin and the adaptor protein TKS5 can be diagnostic, as TKS5 does not seem to localize to other actin-based structures, such as focal adhesions, but is a key component of both podosomes and invadopodia [28] [29] [30] [31] [32] . It is particularly telling that the expression of TKS5 promotes the formation of invado podia in cells that normally do not have them, in a manner dependent on its PX domain 32 . Finally, the colocalization of F-actin, cortactin or TKS5 with focal ECM degradation is often used to identify podosomes and invadopodia.
In 2D culture, the formation of both podosomes and invadopodia is restricted to the ventral surface of the cells. The structures frequently present as isolated puncta, often behind the leading edge of the cell in the case of podosomes, or under the nucleus in the case of invadopodia (FIG. 3) . In some SRC-transformed cells individual invadopodia cluster together into rosettes 1 (FIG. 3) . Rosettes of podosomes have also been observed in vascular smooth muscle cells (FIG. 3) , and occasionally rosettes of invadopodia are seen in human cancer cells. Rosette formation can be promoted by the expression of activated SRC or SRC family kinases, or the activation of endo genous protein kinase C (PKC) family members (hereafter referred to as PKC), RHO family GTPases and certain integrins 22, [33] [34] [35] [36] [37] [38] . It is not known whether there are functional differences between rosettes and individual podosomes or invadopodia. In osteoclasts cultured on glass, individual podosomes form transient circular rings that appear to fuse and form a podosome belt 39 . Under more physiological conditions, osteoclasts will form a similar F-actin-rich structure known as the sealing zone, which is composed of individual podosomes 40 . Perhap s clustering into rosettes and subsequent fusion is a maturation step for podosomes that can occur with the appropriat e stimulus in all cell types.
In 2D culture, podosomes are relatively short-lived (2-20 minutes), whereas invadopodia can persist for several hours 6 . The morphological study of cells with podosomes usually involves plating cells directly onto glass coverslips, whereas to study invadopodia the coverslips are frequently coated with a layer of defined ECM. A systematic analysis of how these culture conditions might affect podosome and invadopodium number, size, distribution and turnover has not been undertaken, although it is known that increasing ECM rigidity increases invadopodiu m formation 41 .
Podosomes and invadopodia in 3D.
Cell culture in 3D more faithfully mimics the in vivo environmen t and has been used to great effect to reveal key differences in the morphology, metabolism and survival of normal and cance r cells. Recent studies have used 3D systems to address podosome and invadopodium form ation and function. In one study, cancer cells were cultured on native basement membrane, and the composition and function of invadopodia were followed over time 42 . Passage of the cells through the basement membrane involved three stages that took place over 7 days: first, formation of invado podia and perforation of the basement membrane at the sites of formation; second, extension and elongation of the invadopodia through and beyond the basement membrane; and third, invadopodium-led migration of the cells through the basement membrane 42 . Similar in-depth studies of podosome formation in 3D have yet to be carried out. However, when vascular smooth muscle cells or human monocyte-derived macrophages are cultured in collagen I or gelled collagen (fibrillar collagen polymerized into a dense gel), respectively, they form long actin-rich protrusions that contain podosome-associated proteins [43] [44] [45] . The extension of long podosome-like structures is also associated with robust degradative activity in human macrophages, dendritic cells and lymphocytes 13, 45, 46 . Similar MMP-dependent protrusive structures have been seen in 3D cultures of SRC-transformed mouse sarcomas, and human melanoma, fibrosarcoma and breast cancer cells [47] [48] [49] . The idea that these 3D structures may represent podosomes and invadopodia is supported by the presence of F-actin together with proteins such as talin, cortactin, focal adhesion kinase (FAK), MT1MMP, N-WASP, paxillin, gelsolin and β1 integrin, although many of these markers are also found in other adhesive structures. It will be important to rigorously establish the characteristics that determine the existence of podosomes and invadopodia in 3D.
Podosomes and invadopodia in vivo.
There is much circumstantial evidence to suggest that podosomes and invadopodia are physiologically relevant structures. For example, loss of the obligatory podosome-associated proteins WASP and SRC results in in vivo defects in macrophage and osteoclast function, respectively 50, 51 . Furthermore, key invadopodium-associated proteins are required for cancer progression in animal models [52] [53] [54] . However, there is currently scant evidence for the existence of invadopodia and podosomes in vivo, although we did recently visualize TKS5-and cortactin-containing rosette-like structures in vascular smooth muscle cells 20 (FIG. 4) . Recent advances in the molecular characterization of these structures, and data obtained using enhanced microscopy techniques, suggest that the formation of podosomes and invadopodia will become widely accepted as a physiological event that is required for the migration of many cell types in vivo.
Induction of podosomes and invadopodia
Many studies have shown that stimulation with growth factors, such as platelet-derived growth factor (PDGF), transforming growth factor-β (TGFβ) and epidermal growth factor (EGF), induces podosome or invadopodium formation in normal and cancer cells, respectively 20, 22, [55] [56] [57] (FIG. 5a) . These stimuli elicit the phosphorylation and/or activation of the key podosome-associated and invadopodium-associated proteins through canonical signalling pathways, especially pathways involving SRC and PKC. Novel mechanisms for podosome and 
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invadopodium initiation that have come to light more recently include integrin signalling, reactive oxygen species (ROS) signalling and microRNA (miRNA)-mediated control. These are discussed below.
Integrin signalling. Integrin receptors directly interact with the ECM and transmit extracellular signals to the cytoplasm (outside-in signalling), as well as information about the status of the cell to the extracellular space (inside-out signalling). Thus, they are ideally placed to modulate invadopodium and podosome biology. Indeed, many studies have described the localization of integrins to podosomes and invadopodia. For example, αvβ3 integrin is found in both the podosomes of osteoclasts and the invadopodia of several cancer types 6, 58 , and the β1 integrin subunit is also found in both podosomes and invadopodia 59, 60 . Few studies have directly addressed the role of the integrins in these structures, although podosome and invado podium formation is modulated by the presence of ECM substrate 13, 33 . Antibody-induced activation of β1 integrin increases ECM degradation 61 , and interference with αvβ3 integrin in osteoclasts results in defective podosome function 62 . More recently, the roles of ECM and integrins in the regulation of podosome and invadopodium formation were investigated in osteoclasts and SRC-transformed fibroblasts 33 , which express both β1 and β3 integrins. Invadopodia still form in the absence of β3 integrin, but the formation of podosomes and invadopodia is inhibited by loss of β1 integrin 33 . Furthermore, phosphorylation of the cytoplasmic tail of β1 integrin promoted the formation of rosettes 33 . Interestingly, acute loss of β1 integrin also promoted the formation of focal adhesions, reinforcing the idea of a reciprocal relationship between these two structures, as described later (FIG. 5a) .
SRC kinases and PKC. SRC family kinases have a pivotal role in the formation of podosomes and invadopodia. The scaffold protein TKS5 was first identified as a SRC substrate, as were other proteins present in these structures, including cortactin, the actin-binding and crosslinking protein 110 kDa actin filament-associated protein (AFAP110; also known as AFAP1) and the integrin effector and adaptor protein p130CAS (also known as BCAR1) 63, 64 . Given this, it is perhaps not surprising that activated SRC promotes podosome or invado podium formation, whereas inhibition of SRC has the opposite effect. SRC stimulates primary actin nucleation, rate of flux at the actin core and formation of the actin cloud and podosome belt within osteoclasts, suggesting that one of its roles is in the initiation of podosome formation 65 . But the observation that the podosomes that do form in SRC-null osteoclasts have a fourfold longer lifespan and lower actin flux than wild-type osteoclasts suggests that SRC is also required for the disassembly of podosomes 65 . How is SRC activated in normal and cancer cells? Few studies have addressed this question directly, although both PDGF and EGF -which promote podosome and invado podium formation -activate SRC family kinases 66 , and SRC mediates integrin signals to the actin cytoskeleton 67 . Furthermore, SRC acts in concert with PKC to regulate the formation of podosomes and invadopodia 34, 56 . For example, experimental activation of PKCα with phorbol esters or by membrane targeting induces AFAP110 to colocalize with and activate SRC through a mechanism that requires phosphoinositide 3-kinase (PI3K) activity 56 . Interestingly, PKC-mediated phosphorylation of AFAP110 and fascin, which is an actin-bundling protein, stabilizes podosomes and invadopodia 47, 68 . Thus, PKC-SRC mediated pathways seem to have a key role in the formation of podosomes and invadopodia.
ROS.
Most ROS in the cell are produced either as a byproduct of oxidative phosphorylation in mitochondria, or by the action of members of the NADPH oxidase (NOX) family. NOX-catalysed ROS production occurs to high levels in phagocytic cells as a host defence mechanism and at lower levels in other cell types to facilitate mitogenesis and motility 69 . In cancer cells, ROS are produced at high levels because of metabolic stress, resulting in DNA damage and apoptosis 70 . More recently, it has become apparent that low-level ROS production in cancer cells, probably mediated by NOX enzymes, facilitates invasion and metastasis 70 . The formation of podosomes and invadopodia depends on ROS, and NOX components and ROS generation have been detected in invadopodia 29 . Interestingly, the podosome-associated and invadopodium-associate d proteins TKS4 and TKS5 share some architectural similarity with the phagocytic NOX organizer protein p47PHOX (also known as NCF1), which promotes catalysis by recruiting p67PHOX (also known as NOXA1) and RAC GTPases to the membrane-associated domain of NOX2 through association with p22PHOX (also known as CYBA). Similarly, the SH3 domains of TKS4 and TKS5 can also associate with Pro motifs in both p22PHOX and p67PHOX 29, 71 and promote NOX catalysis. How do ROS promote invadopodium formation and function? Probable roles include increasing the expression of MMPs, thereby leading to remodelling of the ECM and transient modulation of the catalytic activity of key podosome and invadopodium regulators. For example, PKCs, and perhaps SRC 72 , are activated by ROS 73 . Furthermore, ROS can transiently oxidize and inhibit protein Tyr phosphatases and some lipid phosphatases 74 , which could also promote invadopodium formation. In keeping with this, knockdown of the protein Tyr phosphatase PTPPEST increases the number of invadopodia 29 . It will be important to catalogue all phosphatases that are regulated by invadopodium-produced ROS and determine their effect on invasiveness and migration. miRNAs. miRNAs are highly conserved small RNAs that inhibit gene expression, either by inhibiting translation or by inducing degradation of target mRNAs, and control pathways that are involved in development, tumour growth and metastasis 75, 76 . In vascular smooth muscle cells, miR-143 and miR-145 regulate the switch between differentiated (contractile) and de-differentiated (synthetic or migratory) phenotypes, which occurs in response to vascular stress and injury [77] [78] [79] , by controlling podosome formation both in vitro and in vivo 20 . miRNAs normally repress podosome formation by inhibiting the expression of the key podosome regulators PDGF receptor-α and PKCε (in the case of miR-143) and fascin (in the case of miR-145) 20 . Downregulation of the miRNAs, and subsequent podosome formation, is initiated by a pathway involving PDGF (which is released in response to vascular stress), SRC and p53 (REF. 20) . It is not known whether select miRNAs also regulate invadopodium formation in cancer cells. However, there seems to be an overall downregulation of miRNAs during transformation, metastasis and metastatic relapse 75, 80 , suggesting that this is a possibility worth exploring.
Assembly and turnover
Podosomes and invadopodia are dynamic structures, the formation and turnover of which are tightly controlled. Below, we discuss what is known about the assembly, maturation and turnover of these structures.
Initiation of podosome and invadopodium formation.
The shift from a quiescent to a migratory phenotype is often characterized by the dissolution of focal adhesions and the formation of podosomes or invadopodia 14, 81 at 
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the sites of ECM contact (FIG. 5) . Podosomes and invadopodia have many of the same components as focal adhesions, which are structures that are associated with stable attachment to the ECM -their dissolution is required for cell motility. One study has suggested that there is a reciprocal relationship between focal adhesions and invadopodia, with FAK (a scaffold and Tyr kinase that, together with SRC, promotes the turnover of focal adhesions) functioning as a negative regulator of invadopodia through the spatial control of SRC 81 . In this view, phosphorylation of FAK at Tyr397 promotes its association with SRC and the phosphorylation of SRC substrates at focal adhesions. Depletion of FAK releases active SRC to promote the phosphorylation of invadopodiumassociate d proteins and increase invadopodium formation. Other studies have confirmed that the inhibition of FAK promotes invadopodium formation 82, 83 . However, there are also reports showing that FAK is present in invado podia, and that increased FAK expression promotes invadopodium formation 41, 84 . Furthermore, the FAK-related kinase PYK2 is an obligate component of osteoclast podosomes [85] [86] [87] [88] . In SRC-transformed fibroblasts, the formation of invadopodia is initiated in the vicinity of focal adhesions in response to the focal generation of phosphatidylinositol-3,4-bisphosphate (PtdIns(3,4) P 2 ) 30 . This lipid recruits TKS5 by associating with its PX domain 28 . Mueller and co-workers 15 proposed that the aggregation of cortactin at sites of ECM attachment was a key early step in invadopodium formation. Condeelis and co-workers 89 showed that TKS5 colocalized with cortactin to invadopodium precursors and suggested that TKS5 may be the scaffold that recruits cortactin. In this model, the focal generation of PtdIns(3,4)P 2 is the key initiating step in podosome and invadopodium formation; however, it is not clear how this lipid is generated at, or localized to, the membrane near focal adhesions (FIG. 5a) .
Assembly of podosomes and invadopodia. Currently, we do not fully understand the mechanism by which podosomes and invadopodia are assembled following TKS5 and cortactin recruitment to the membrane. TKS5 can bind, directly or indirectly, to the key actin regulators NCK1, NCK2, N-WASP and growth factor receptor-bound protein 2 (GRB2) 30, 31 . Cortactin also associates with several actin-regulatory proteins, including N-WASP and the ARP2/3 complex; these proteins then form a complex with the small GTPase CDC42 (REF. 55 ), WASP-interacting protein (WIP) and dynamin, all of which are required for podosome and invadopodium formation 6 . We speculate that one or more of these proteins act as a bridge between cortactin and TKS5 in a manner dependent on the phosphorylation status of cortactin. Cortactin is phosphorylated by several kinases, including those of the SRC, p21-activated kinase (PAK) and extracellular signal-regulated kinase (ERK) families, which regulates its interaction with other proteins 54 . For example, Tyr phosphorylation of cortactin in response to EGF stimulation causes its dissociation from cofilin enabling cofilin to generate barbed ends by severing actin filaments, and thus initiating actin polymerization and invadopodium formation 89 (FIG. 5b) . Sub sequent cortactin dephosphorylation blocks the sever ing ability of cofilin, to enable invadopodium stabilization and the degradative activity of invadopodia 55, 89 . The role, regulation, kinetics of recruitment and interrelationship of other proteins in podosome and invadopodium assembly will be an important topic for future research.
Maturation of podosomes and invadopodia. Cortactin and TKS4 have been shown to regulate the secretion and localization, respectively, of MMPs at invadopodia 10, 16, 90 , and seem to have a role in the maturation of podosomes and invadopodia. In keeping with a key role for cortactin, its recruitment to future sites of ECM degradation immediately precedes the trafficking of proteases to these sites 15 . By contrast, knockdown of TKS5 inhibits invadopodium formation without affecting the secretion of metalloproteases 32 . Loss of TKS4 has an intermediate phenotype, as immature invadopodia (which contain TKS5 and cortactin) are formed and MMPs are secreted, but MT1MMP fails to localize to the invadopodia and ECM degradation does not take place 90 . Together, these data suggest a model in which TKS5 and cortactin act to generate invadopodia and enable them to secrete metallo proteases, respectively (FIG. 5) . TKS4 subsequently localizes and/or stabilizes MT1MMP in the structure to allow focal activation of MMPs and subsequent ECM degradation (FIG. 5c) .
We have already discussed the localization of MT1MMP to podosomes and invadopodia as a key maturation step. A brief description of how MT1MMP localization is controlled by its intracellular trafficking and its binding to ECM serves to illustrate the complexity of its regulation. MT1MMP is delivered to invadopodia in many ways. First, a significant fraction is derived from endocytic recycling, similarly to integrins. MT1MMP is efficiently internalized by both clathrin-mediated endocytosis and caveolae-mediated endocytosis, with trafficking to endosomal and lysosomal compartments for either recycling or degradation. The 20-amino-acid cytoplasmic domain of MT1MMP has a key role in regulating its endocytosis 91 . Currently, attention focuses on SRC-mediated phosphorylation of MT1MMP within its AP2 clathrin adaptor binding sequence, which is predicted to impede endocytosis 91 . SRC also phosphorylates endophilin A2, reducing its affinity for the GTPase dynamin, thus inhibiting clathrin-mediated endo cytosis 92 . In addition, the clustering of MT1MMP with β1 integrin as a consequence of type I collagen binding slows down endocytosis 93 . Second, MT1MMP can be mobilized from intracellular stores by a RAB8-dependent secretory pathway 94 . Third, there is an important role for the coordinated actions of the actin cytoskeleton and the exocytic machinery. In this regard, activated CDC42 and RHOA promote association of the polarity regulator RAS GTPase-activatinglike protein IQGAP1 (which links microtubules with the actin cytoskeleton) and the exocyst complex (which localizes to invadopodia and is required for MT1MMP localization) 95, 96 . As MT1MMP is not localized at Each stage of invadopodium formation is depicted on three levels: the basic shape of the structure in relation to the cell (top), a simple representation of key proteins in relation to the cell membrane (middle) and a detailed molecular overview (bottom). a | During initiation of invadopodium formation, cells establish focal adhesions with the extracellular matrix (ECM) through the interaction of integrins, SRC and Tyr397-phosphorylated focal adhesion kinase (FAK). In invading cells, a switch occurs to release SRC, enabling it to bind and phosphorylate Tyr kinase substrate with five SH3 domains (TKS5) (as well as phosphoinositide 3-kinase (PI3K) and protein kinase C (PKC). Phosphorylated TKS5 will then localize to regions containing phosphatidylinositol-3,4-bisphosphat e (PtdIns(3,4)P 2 ) . The intracellular switch is initiated by growth factors such as epidermal growth factor (EGF), platelet-derived growth factor (PDGF) and transforming growth factor-β (TGFβ). As TKS5 colocalizes with cortactin in precursors of invadopodia, it might form the scaffold that recruits cortactin. b | The formation of invadopodia occurs through the recruitment and activation of the actin regulatory complex ARP2/3 and WASP-interacting protein (WIP), the phosphorylation of key invadopodium components, such as cortactin, TKS5, fascin and 110 kDa actin filament-associated protein (AFAP110), and the production of reactive oxygen species (ROS). TKS5 binds NCK1, NCK2, growth factor receptor-bound protein 2 (GRB2) and neural Wiskott-Aldrich syndrome protein (N-WASP) (the TKS5-N-WASP interaction is not shown here). Cortactin associates with N-WASP and the ARP2/3 complex (the cortactin-ARP2/3 interaction is not shown here), and will generate a complex of WIP and dynamin during invadopodia formation. Phosphorylation of both cortactin (by SRC, p21-activated kinase (PAK) and extracellular signal-regulated kinase (ERK)) and TKS5 (by SRC) regulate invadopodium formation. In addition, phosphorylation of cortactin by EGF causes dissociation from cofilin to initiate actin polymerization and invadopodium formation. c | During maturation, invadopodia promote the degradation of the ECM by coordinating the secretion of matrix metalloprotease 2 (MMP2) and MMP9 and enabling the delivery (potentially through microtubules) and presentation of membrane type 1 MMP (MT1MMP) to the tip of the protruding structure, through the interaction of these proteases with key invadopodium components such as cortactin, Tyr kinase substrate with four SH3 domains (TKS4) and β1 integrin. Dephosphorylation of cortactin blocks the severing ability of cofilin and enables the stabilization of invadopodia. The mechanisms by which the proteins associate, and how they are temporally regulated, are largely unknown and should be explored further. Faded-out circles represent proteins that are present during maturation, but have unknown roles in ECM degradation. Dotted arrows indicate a regulatory pathway for which the mechanism is unknown. Dashed lines represent an enzyme-substrate interaction. P, phosphate; RTK, receptor Tyr kinase.
Epithelial-mesenchymal transition
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invadopodia in the absence of TKS4, it will be important to determine how TKS4 interfaces with the complex control of MT1MMP turnover. These data suggest that MT1MMP accumulates at invadopodia through a balance of endocytosis and exocytosis, providing many intervention points at which the cell surface expression of this key protease may be controlled. The microtubule network and the actin cyto skeleton are closely linked and cooperate during planar cell migration 97 . Similar cooperation between microtubules and the actin cytoskeleton seems to promote podosome and invadopodium formation and function. For example, microtubules are required for podosome formation and turnover in macrophages and osteoclasts 6, 98 , and a recent study showed that the elongation of invadopodia into basement membranes depends on a microtubule network that forms at the base of the structure; this suggests that microtubules deliver components to the protruding tip 42 (FIG. 5) . Furthermore kinesins, which are motor proteins that transport cargo along microtubules, are required for the delivery of MT1MMP to podosomes 99 . How do the actin and microtubule networks cooperate? Myosin, which helps to transport organelles and vesicles along actin, also transports microtubule ends along actin tracks to foci of cortical actin during cell migration 100 . In dendritic cells, myosin inhibition by blebbistatin prevents podosome elongation and invasion 13 . These data suggest that the trafficking of podosome-and invadopodium-associated proteins regulates their elongation and invasion capabilities; although it remains to be determined which key proteins are trafficke d in this way.
Turnover of podosomes and invadopodia. Podosomes and invadopodia are dynamic structures, with half-lives of actin turnover ranging from minutes to hours. However, almost nothing is known about how their turn over is regulated, nor is it clear whether the entire structure disassembles. Most studies follow only the turnover of actin, although fluorescently tagged cortactin and AFAP110 have also been visualized 68, 101 . It seems possibl e that a core structure remaining in the plasma membrane becomes uncoupled from actin polymerization to effect turnover. Alternatively, parts of the structures may turnover rapidly. For example, in the actin comets of invadopodia, the actin head structure turns over rapidly, whereas the filamentous tail region persists for hours 27 . Protein phosphorylation is important for podosome or invadopodium formation and/or turnover. The Tyr phosphorylation of TKS5 is crucial for the formation of invadopodia 31 , whereas both the Tyr phosphorylation of cortactin and the Ser phosphorylation of AFAP110 promotes invadopodium turnover 68, 89 . Phosphatases probably have key roles in controlling podosome and invadopodium formation and turnover, but few have been characterized to date. Protein Tyr phosphatase-ε (PTPε) has a positive role in osteoclasts through the dephosphorylation and subsequent activation of SRC at Tyr527 (REF. 102 ), and PTP1B is required for invadopodium formation 103 . By contrast, the Tyr phosphatase PTPPEST negatively regulates invadopodium formation 29 . The 5′ inositol phosphatase synaptojanin is localized to invadopodia and is required for their formation 104 , whereas the 3′ inositol phosphatase and tumour suppressor phosphatase and tensin homologue (PTEN) represses invadopodium form ation 105 . Finally, the Ser protease calpain promotes dendritic cell podosome turnover by cleaving the podosomeassociate d proteins talin, PYK2 and WASP 106 . It is important that these studies are extended to determine the effect of lipid and protein phosphatases on turnover, as well as to isolate other classes of regulators.
Podosomes and invadopodia in biology
Several studies have suggested that podosome-associate d proteins might have a role in embryonic development. Furthermore, several human diseases that are a consequence of abnormal cell migration or invasion have been linked to the deregulation of podosome or invadopodium components. These include the genetic diseases Wiskott-Aldrich syndrome and Frank-ter Haar syndrome, as well as atherosclerosis, tumour progression and metastasis.
Podosomes in development.
During development, cells migrate from a centralized location to distal sites in the developing embryo. Cell migration begins in gastrulation and later becomes restricted to certain cell types, particularly those such as neural crest derivatives that have undergone epithelial-mesenchymal transition (EMT). Genes involved in the control of EMT during embryonic development (for example, the transcription factors TWIST, SNAIL and SLUG) also regulate tumour formation and cancer progression [107] [108] [109] 110 . Furthermore, invadopodia are frequently found in cancer cells that have undergone EMT, and TWIST can promote invadopodium formation 111 . However, few studies have investigated whether podosomes and/or podosome-associate d proteins are required for embryonic development. Recently, a mutation in the gene encoding the podosom eand invadopodium-associated protein TKS4 was shown to cause the autosomal recessive disorder Frank-ter Haar syndrome. This syndrome is characterized by skeletal, cardiac, metabolic and ocular defects, which are replicated in a mouse model of TKS4 loss 112 . These phenotypes are consistent with defects in neural crestderived cells. To date, it is unclear whether loss of TKS4 results in abnormal podosome formation in patients with Frank-ter Haar syndrome, or what mechanistic role it has in this disease. However, we have recently used a zebrafish model to implicate the related protein TKS5 in neural crest cell migration, and detected podosomes in neural crest stem cells in culture (D.A.M. and S.A.C., unpublished observations). Interestingly, SRC family kinases, MT1MMP, ADAM19 and collagen, all of which are podosome-associated proteins, seem to have a role in cell movement during gastrulation [113] [114] [115] [116] [117] [118] [119] . Podosomeassociated proteins are also involved in developmental syndromes that are characterized by craniofacial disorders 120 . Although it is possible that these defects are attributed to increased apoptosis or decreased proliferation, it seems more likely that podosome-associated proteins are required for cell migration during development.
Podosome-and invadopodium-associated proteins in disease. Wiskott-Aldrich syndrome is an X-linked recessive disease in which patients present with eczema, thrombocytopenia and severe immune deficiencies 121 . It is caused by mutations in the gene encoding the actin-binding protein WASP, which is predominately expressed by haematopoietic cells 121 . The observation that macrophages and dendritic cells from patients with Wiskott-Aldrich syndrome are defective in podosome formation provided the first link between podosomes and a human disease 50 . It has recently been proposed that chemotactic factors cause the recruitment of WASP to focal adhesions, where it acts as a scaffold between integrins and the actin filaments forming in the podosome core 122 .
Atherosclerosis is the accumulation of vascular smooth muscle cells in response to injury and vascula r stresses such as ischaemia and is attributed to both increased cell proliferation and cell migration. As noted earlier, miR-143 and miR-145 control the switch of vascular smooth muscle cells from the differentiated state to the synthetic, motile state 123 . Furthermore, reduced expression of these miRNAs was noted in aortic aneurysms 78 . Deletion of the locus encoding miR-143 and miR-145 results in arterial thickening and a blunted response to vasopressive stimuli that is correlated with increased podosome formation and cell migration in primary aortic smooth muscle cells in vivo and in vitro 20, 78 . Interestingly, TGFβ, which is activated by disruption of blood flow and ischaemia, induces podosome rosettes in arterial endothelial cells that are cultured ex vivo 21 . Together, these data suggest that podosome formation has a role in vascular homeostasis.
There is a growing body of literature describing the role of invadopodium-associated proteins in invasive cell behaviour in tissue culture systems, and several invadopodium-associated proteins are known to be expressed in human cancer tissue. For example, cortactin levels correlate with aggressiveness in squamous cell carcinoma of the head and neck 53 . TKS5 has been detected in several human tumour samples 32 , and sites of invadopodium formation can degrade ECM in human lobular breast carcinoma tissue examined ex vivo 124 . However, few studies have critically examined the role of invadopodia in tumorigenesis in vivo. One of the earliest studies examined AMAP1 (also known as MYCBPAP), an ADP-ribosylation factor-GTPase activating protein (ARF-GAP) that acts as a bridge between paxillin and cortactin and colocalizes with them at invadopodia 125 . In breast cancer cells, the expression of mutant AMAP1 proteins that were unable to mediate trimeric complex formation with cortactin and paxillin had only a minor effect on primary tumour growth in mammary fat pads, but a more pronounced effect on subsequent metastasis to the lung. Such a phenotype is consistent with studie s showing that invadopodium-associated proteins are typically not required for tumour cell growth in vitro. However, an interesting layer of complexity has emerged from the in vivo study of other invadopodium-associated proteins. For example, inhibition of MMPs prevents primary tumour growth in many mouse models of cancer 126 . Overexpression of MT1MMP in cancer cells promotes tumorigenesis and, conversely, inhibition of MT1MMP reduces tumour growth and invasion 127 . Knockdown of cortactin impairs tumour growth in a model of head and neck cancer 53 , and knockdown of TKS5 also impairs primary tumour growth 52 . Why the discrepancy between the cell-based and animal models? The consideration of findings derived from 3D culture systems perhaps offers a way to rationalize the data. Tumour cell growth in 3D matrices of type I collagen requires MT1MMP and metalloprotease activit y, whereas growth in 2D on top of type I collagen does not 49, 127 . Similarly, cortactin promotes growth in the 3D culture environments of agarose and matrigel 53 . The Ser/Thr kinase LIM domain kinase (LIMK1) and LIMK2 and the adaptors TKS4 and TKS5 are also required for efficient growth in, but not on top of, 3D collagen (REF. 128 and M. Buschman, B. Diaz and S.A.C., un published observations). The mechanism (or mechanisms) by which invadopodia are required for 3D growth has not yet been fully explored, but might involve the induction of proteolysis. In the case of cortacti n knockdown, growth can be rescued by coculture with cortacti n-expressing cells, suggesting that invado podium-directed proteolysis may release autocrine growth factors from the cell surface 53 . Focal ECM degradation might also promote ECM-integrin signalling, and may be necessary for expansion of the tumour into the microenvironment. In vivo, invadopodiummediated regulation of pericellular proteolysis could also be responsible for the regulated production of proangiogenic factors such as vascular endothelial growth factor (VEGF), which might explain the reduced angiogenesis observed in tumours in which TKS5 has been knocked down 52 . Finally, many of the stromal cells that are present in the tumour microenvironment, including macrophages, fibroblasts and endothelial cells, can form podosomes. It will be interesting to determine what role podosomes might have in tumour progression.
Conclusions and perspectives
Tremendous strides have been made in our understanding of podosomes and invadopodia in recent years, but many important questions remain. Are there molecular differences between the two structures? What roles do they have in the mechanics of cell migration? How many cell types form podosomes during development? What are the master switches that control their formation and function? What role does the ECM have in the formation of these structures? How is pericellular proteo lysis controlled by podosomes and invadopodia? Which diseases might be caused by alterations in podosome biolog y? How do invadopodia promote tumour growth and progression?
Even as we address these questions, there is already strong circumstantial evidence to suggest that modulation of podosomes and invadopodia might represent a viable therapeutic strategy to alter the course of several diseases. For example, compounds that inhibit the formation of podosomes and invadopodia might be valuable for the treatment of atherosclerosis and cancer.
Transient activators of podosome formation might also ameliorate the progressive skeletal anomalies of infants with Frank-ter Haar syndrome or perhaps other craniofacial syndromes, as well as immunodeficiency. Many of the known components of podosomes and invadopodia are scaffolding or adaptor proteins with no catalytic activity, and are therefore unlikely drug targets. In the future, it will be important to identify key enzymatic regulators, with an eye to the generation of novel targete d therapies.
